Vanta Bioscience Ltd Quarterly Results
Q4 FY22-23 Results Summary
Revenue
The revenue stands at ₹0.63 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 77.66 per cent from ₹2.82 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹-1.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 136.36 per cent from ₹-0.55 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT
PBDT stands at ₹-1.56 crore, reflecting a quarter-on-quarter *(QoQ) increase of 48.34 per cent from ₹-3.02 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-1.61 crore, reflecting a quarter-on-quarter *(QoQ) increase of 62.82 per cent from ₹-4.33 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit
Net Profit stands at ₹-1.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 63.80 per cent from ₹-4.42 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Vanta Bioscience Ltd Earnings
- YOY
- QOQ
Vanta Bioscience Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Vanta Bioscience Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Vanta Bioscience Ltd Financial Reports
Vanta Bioscience Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Tejnaksh Health. | 0.37% | -4.22% | 1.13% | -10.67% | 11.48% | -27.41% |
| Transgene Biotek | -1.06% | 4.09% | -4.11% | -7.59% | 19.15% | -31.37% |
| Nexus Surgical | 2.60% | -1.89% | 64.67% | 60.81% | 86.43% | 75.56% |
| Family Care | -0.50% | 0.50% | -2.91% | -33.33% | -27.54% | -64.41% |
| Looks Health | -4.19% | -6.73% | 4.21% | -5.77% | 26.21% | 80.83% |
| Dr Lalchand. Lab | -4.99% | -4.99% | 6.76% | 9.93% | -47.26% | -55.81% |
| Boston Commerce | 4.98% | 26.92% | 58.46% | 33.16% | -8.66% | -8.88% |
Company Info
Company Information
Managing Director : Dopesh Raja Mulakala
Independent Non Exe. Director : Padmanabhuni Venkata Appaji
Independent Non Exe. Director : Kathyayani Gonuguntla
Independent Non Exe. Director : Yogeswara Rao Danda
Company Sec. & Compli. Officer : Pooja Kothari